Clinical Trial Update: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE) [Phase 4]

View source ↗

Summary

Phase 4 study comparing 1% azithromycin ophthalmic solution to rewetting drops in individuals with history and current contact lens-related dry eye; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Azasite (azithromycin ophthalmic solution) 1% (azithromycin ophthalmic solution)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Contact Lens Dry Eye | Phase 4 | Status: COMPLETED